Cargando…

May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2?

Detalles Bibliográficos
Autores principales:	Spina Tensini, F., Spina Tensini, T., Franklin, G.L., Teive, H.A.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299859/ https://www.ncbi.nlm.nih.gov/pubmed/32575004 http://dx.doi.org/10.1016/j.parkreldis.2020.06.012

Ejemplares similares

Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
por: Pallett, Scott J C, et al.
Publicado: (2022)

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
por: Yoon, Sarang K., et al.
Publicado: (2022)

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
por: Altarawneh, Heba N., et al.
Publicado: (2022)

More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells
por: Rijkers, Ger, et al.
Publicado: (2020)

A case of probable Parkinson's disease after SARS-CoV-2 infection
por: Cohen, Mikhal E, et al.
Publicado: (2020)

Chloroquine drops against SARS-CoV-2 infection
por: Kumar, Jogender, et al.
Publicado: (2022)

Enoxaparin’s potential mechanisms against SARS-CoV-2
por: Afsharirad, Bentelhoda, et al.
Publicado: (2023)

Heterogenous Exposures May Drive SARS-CoV-2 Positivity Among Different Subpopulations
por: Allan-Blitz, Lao-Tzu, et al.
Publicado: (2021)

How Losing Sleep Following Vaccination May Weaken the Response to SARS-CoV Vaccines
por: Akhtar, Nasreen, et al.
Publicado: (2022)

Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues…
por: Sharma, Ridhima, et al.
Publicado: (2021)

Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua
por: Maier, Hannah E., et al.
Publicado: (2022)

Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice
por: Sun, Shihui, et al.
Publicado: (2021)

SARS-CoV-2 may underlie NMDA-related autoimmune encephalitis and venous sinus thrombosis
por: Finsterer, Josef
Publicado: (2023)

Fighting the Battle against SARS-CoV-2 as Gastroenterologists in Italy
por: Pagnini, Cristiano, et al.
Publicado: (2020)

Protective humoral immunity in SARS-CoV-2 infected pediatric patients
por: Zhang, Yaguang, et al.
Publicado: (2020)

Tracking immune correlates of protection for emerging SARS-CoV-2 variants
por: Nilles, Eric J, et al.
Publicado: (2023)

Gastrointestinal involvement of COVID-19 and potential faecal transmission of SARS-CoV-2
por: Song, Min, et al.
Publicado: (2020)

Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
por: Chen, Xiaosu, et al.
Publicado: (2023)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Ebselen, a new candidate therapeutic against SARS-CoV-2
por: Haritha, C.V., et al.
Publicado: (2020)

Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
por: Karim, Salim S Abdool
Publicado: (2021)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
por: Blumenthal, Kimberly G., et al.
Publicado: (2021)

hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants
por: Liu, Junli, et al.
Publicado: (2021)

Iodide supplementation of the anti-viral duox-lactoperoxidase activity may prevent some SARS-CoV-2 infections
por: Smith, Michael L., et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020
por: Wang, Shichun, et al.
Publicado: (2022)

The proximal origin of SARS-CoV-2
por: Andersen, Kristian G., et al.
Publicado: (2020)

Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
por: Chemaitelly, Hiam, et al.
Publicado: (2021)

Cross-reactive antibody immunity against SARS-CoV-2 in children and adults
por: Fraley, Elizabeth, et al.
Publicado: (2021)

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
por: Fang, Zhenhao, et al.
Publicado: (2022)

7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
por: Marking, Ulrika, et al.
Publicado: (2023)

A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China
por: Huang, Rui, et al.
Publicado: (2020)

Highly contagious but less severe COVID-19 caused by new SARS-CoV-2 sublineages may abate the pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

An action plan for pan-European defence against new SARS-CoV-2 variants
por: Priesemann, Viola, et al.
Publicado: (2021)

Proposing a nasal trehalose‐induced autophagy approach against SARS‐CoV 2
por: Pajokh, Mojde, et al.
Publicado: (2021)

Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac
por: Chen, Yuxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kk03tpaec8hbglr96l81f21t4m